NEW YORK (GenomeWeb) – Roche said today that its diagnostics revenues grew 6 percent year over year for the first quarter of 2017, driven by growth in its centralized and point-of-care solutions segment.

For the three months ended March 31, the Swiss pharmaceutical and diagnostics company reported overall revenues of CHF 12.94 billion ($13.07 billion), up 4 percent from CHF 12.41 billion in Q1 2016.

In diagnostics, Roche reported revenues of CHF 2.77 billion, up from CHF 2.61 billion in 2016.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.